ADVANCING MEDICINE FOR LIFE
DEAD

Serial Number

87876584

Owner

The University of North Carolina at Chapel Hill

Attorney

Arles A. Taylor, Jr.

First Use Date

Nov 30, 2017

Filing Date

Apr 13, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ADVANCING MEDICINE FOR LIFE Trademark

Serial Number: 87876584 • Registration: 5944986

ADVANCING MEDICINE FOR LIFE is a trademark filed by The University of North Carolina at Chapel Hill on April 13, 2018. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

The University of North Carolina at Chapel Hill (47 trademarks)

Office of Technology Development
Chapel Hill, NC 275994105

Entity Type: 99

Trademark Details

Filing Date

April 13, 2018

Registration Date

December 24, 2019

First Use Anywhere

November 30, 2017

First Use in Commerce

November 30, 2017

Published for Opposition

September 18, 2018

Cancellation Date

July 10, 2026

Goods & Services

Charitable fundraising services, namely, university development services for promoting research, education and other activities relating to pharmacy practice, pharmaceutical sciences and pharmacology

Educational services, namely, developing and providing courses of instruction, seminars and webinars in the field of pharmacy practice, pharmaceutical sciences and pharmacology; educational services, namely, developing and providing courses of instruction for pharmacology to be held at a university, high school, online or public forum in pharmacy practice, pharmaceutical sciences and pharmacology to provide training, degrees, certifications for students in pharmacy practice, pharmaceutical sciences and pharmacology; educational services, namely, providing online non-downloadable publications in the nature of brochures and newsletters, and non-downloadable audio and audio visual files, all in the field of pharmacy practice, pharmaceutical sciences and pharmacology, including research programs, job listings, internship opportunities, events, and funding opportunities; educational services, namely, providing internships in the field of pharmacy practice, pharmaceutical sciences and pharmacology; education services, namely, designing and creating education programs, curriculum, resource material in the areas of pharmacy practice, pharmaceutical sciences and pharmacology

Scientific research in the field of pharmacy practice, pharmaceutical sciences and pharmacology; medical research in the fields of pharmacy practice, pharmaceutical sciences and pharmacology; research services and research programs, namely, development of protocols and systems for identifying and addressing issues associated with pharmacy practice, pharmaceutical sciences and pharmacology around the world; online non-downloadable software platforms for project and task management, data sharing, knowledge management, and team communication and collaboration for pharmacology research efforts around the world

Business venture development and management services for commercializing research-based innovations between scientists and industry and government; business consulting services relating to industry collaboration, contract research and licensing opportunities relating to pharmacy practice, pharmaceutical sciences and pharmacology; business consulting services relating to drug discovery-development and regulatory issues relating to pharmacy practice, pharmaceutical sciences and pharmacology; industry collaboration services, namely, providing a shared environment consisting of meeting and gathering areas to entrepreneurs, start-ups, existing businesses and non-profits for the purpose of promoting collaboration to achieve benefits in pharmacy practice, pharmaceutical sciences and pharmacology; providing programming and events to promote collaboration and knowledge transfer

Filing History

CANCELLED SEC. 8 (6-YR)
Jul 10, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 24, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Dec 24, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 16, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 15, 2019 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 21, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 21, 2019 CRFA
ASSIGNED TO LIE
Oct 21, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 15, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 17, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jun 17, 2019 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jun 17, 2019 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 21, 2019 EXRA
STATEMENT OF USE PROCESSING COMPLETE
May 18, 2019 SUPC
SOU EXTENSION 1 GRANTED
May 18, 2019 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 18, 2019 AITU
USE AMENDMENT FILED
May 13, 2019 IUAF
SOU EXTENSION 1 FILED
May 13, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
May 13, 2019 EEXT
TEAS STATEMENT OF USE RECEIVED
May 2, 2019 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 13, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 18, 2018 NPUB
PUBLISHED FOR OPPOSITION
Sep 18, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 29, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 16, 2018 CNSA
ASSIGNED TO EXAMINER
Aug 1, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2018 NWOS
NEW APPLICATION ENTERED
Apr 17, 2018 NWAP